Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)

Clinical trial NCT00929201 · COMPLETED

Trial details

NCT number: NCT00929201
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-01-01
Primary completion: 2008-03-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.